Lysosomal Storage Diseases Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

By Treatment (Enzyme Replacement Therapy, Stem Cell Therapy, Substrate Reduction Therapy, others), By Indication (Gaucher's Disease, Fabry Disease, Pompe's Disease, Mucopolysaccharidosis, others), By End User (Hospitals, Clinics), by region, and Competition

Published	Pages	Publisher	Report code
Oct 2023	189	TechSci Research	ASDR-638156

Published: Oct 2023 - Pages : 189 - Publisher : TechSci Research - Report code : ASDR-638156

1. Pfizer Inc.
2. Sanofi SA
3. BioMarin Pharmaceutical Inc
4. Actelion Ltd.
5. Raptor Pharmaceutical Corp.
6. Protalix Biotherapeutics Inc.
7. Amicus Therapeutics Inc.

Global Lysosomal Storage Disease Partnering 2014-2019

This report can be of interest as well:

Global Lysosomal Storage Disease Partnering 2014-2019

Published: March, 2019 | Report code: ASDR-481666